Cardiovascular toxicity in breast cancer patients – contributors and role of cardioprotective drugs

Breast cancer (BC) patients treated with anthracyclines and/or anti-HER2-targeted therapies (AHT) are highly associated with cardiovascular toxicity (CVT). Our objective was to evaluate the risk of CVT secondary to cancer treatment and the role of cardioprotective-drugs (CPD) in BC patients. We col...

Full description

Bibliographic Details
Main Authors: Miguel Martins Carvalho, Ricardo Alves Pinto, Tânia Proença, Inês Costa, Nuno Tavares, Mariana Paiva, Carla Sousa, Filipe Macedo
Format: Article
Language:English
Published: PAGEPress Publications 2023-03-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/2514